Ownership and insider activity for Incannex Healthcare Limited (IXHL): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound is currently undergoing Phase II clinical evaluation for the treatment of obstructive sleep apnea (OSA).
Price
| Price | $3.59 |
| Market Cap | $43M |
| Exchange | NASDAQ |
| Country | AU |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2025-11-14 | Valentine Troy | A-Award | 11,302,608 | |
| 2025-11-14 | Clark Robert | A-Award | 1,686,956 | |
| 2025-11-14 | Widdows Peter | A-Award | 1,686,956 | |
| 2025-11-14 | Swan Joseph | A-Award | 869,565 | |
| 2025-11-14 | Latham Joel | A-Award | 22,608,692 | |
| 2025-11-14 | Anastassov George | A-Award | 1,686,956 | |
| 2024-10-23 | Barbato Luigi M. | A-Award | 100,476 | |
| 2024-10-21 | Barbato Luigi M. | |||
| 2024-06-30 | Swan Joseph | |||
| 2023-12-21 | Valentine Troy | A-Award | 670,000 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4573 | $508740 | $229582 | $93716 | $3.6M | $9.1M | $37.5M | $33.3M | $5.9M | $15.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $5720 | $8119 | $10475 | $84279 | $409741 | $169326 | $318806 | $287475 | $10.0M | $4.6M |
| Inventory | $58216 | $227406 | $223831 | $153369 | $181596 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $114209 | $842438 | $541891 | $384693 | $4.2M | $9.3M | $38.0M | $34.6M | $16.2M | $20.0M |
| Property, Plant & Equipment | $24733 | $44198 | $98181 | $85775 | 0 | 0 | 0 | $1.2M | $845000 | $485000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $205994 | $117152 | $71431 | $49580 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | $344938 | $1.0M | $711506 | $520049 | $4.2M | $9.3M | $38.0M | $35.8M | $17.0M | $20.4M |
| Accounts Payable | $141916 | $537622 | $497548 | $377676 | $585063 | $232983 | $1.3M | $2.6M | $527000 | $6.1M |
| Short-term Debt | $698878 | 0 | $201030 | $65268 | 0 | 0 | 0 | 0 | 0 | $184000 |
| Total Current Liabilities | $1.0M | $774348 | $1.1M | $938952 | $1.1M | $756115 | $2.0M | $3.8M | $5.6M | $7.0M |
| Long-term Debt | 0 | $398893 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $1.0M | $1.2M | $1.1M | $938952 | $1.1M | $754620 | $2.0M | $4.5M | $5.8M | $7.1M |
| Retained Earnings | -$809009 | -$22.2M | -$25.2M | -$27.9M | -$32.4M | -$44.0M | -$59.0M | -$138.8M | -$110.7M | -$157.6M |
| Total Equity | -$700356 | -$169451 | -$385294 | -$418902 | $3.1M | $8.6M | $36.0M | $31.3M | $11.2M | $13.4M |
| Total Debt | $698878 | $398893 | $201030 | $65268 | 0 | 0 | 0 | $784160 | $373000 | $258000 |
| Net Debt | $694305 | -$109847 | -$28552 | -$28448 | -$3.6M | -$9.1M | -$37.5M | -$32.5M | -$5.5M | -$14.8M |
| Working Capital | -$931086 | $68090 | -$554909 | -$554259 | $3.2M | $8.6M | $36.0M | $30.8M | $10.6M | $13.0M |
Financial Health
| Piotroski F-Score | 3 |
| Altman Z-Score | -13.23 |
Related companies: AGEN · CGTX · IRD · LUCD · SCLX · SEER · STSS
Explore sector: Healthcare · Biotechnology
More sections of IXHL: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks